Late blood pressure reduction in SHR subjected to transient captopril treatment in youth: possible mechanisms
Jazyk angličtina Země Česko Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
18597587
DOI
10.33549/physiolres.931615
PII: 1615
Knihovny.cz E-zdroje
- MeSH
- antihypertenziva aplikace a dávkování MeSH
- hypertenze farmakoterapie patofyziologie MeSH
- inhibitory ACE aplikace a dávkování MeSH
- kaptopril aplikace a dávkování MeSH
- krevní tlak účinky léků MeSH
- krysa rodu Rattus MeSH
- modely nemocí na zvířatech MeSH
- nifedipin farmakologie MeSH
- potkani inbrední SHR MeSH
- rozvrh dávkování léků MeSH
- sympatický nervový systém účinky léků patofyziologie MeSH
- vazodilatancia farmakologie MeSH
- vazokonstrikce účinky léků MeSH
- věkové faktory MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- antihypertenziva MeSH
- inhibitory ACE MeSH
- kaptopril MeSH
- nifedipin MeSH
- vazodilatancia MeSH
Spontaneously hypertensive rats (SHR) are characterized by enhanced nifedipine-sensitive component of sympathetic vasoconstriction. Our study tried to elucidate the mechanisms responsible for long-term reduction of blood pressure (BP) in SHR subjected to early transient captopril treatment. Adult untreated SHR aged 30-34 weeks were compared with animals subjected to chronic captopril treatment for 6 weeks either in youth (between 4 and 10 weeks of age) or in adulthood (between 24 and 30 weeks of age). Antihypertensive effects of captopril were more pronounced in young than adult SHR. This was due to greater attenuation of sympathetic and nifedipine-sensitive BP components and prevention of residual BP rise in young captopril-treated SHR in which the reductions of nifedipine-sensitive BP component and residual BP persisted for 20 weeks after captopril withdrawal. The magnitude of nifedipine-sensitive component of sympathetic vasoconstriction is decisive for BP maintenance not only in untreated SHR but also in SHR during active captopril treatment by or after its withdrawal.
Citace poskytuje Crossref.org
Altered Balance between Vasoconstrictor and Vasodilator Systems in Experimental Hypertension
Research on Experimental Hypertension in Prague (1966-2009)